
Eli Lilly Bets on Oura Rings
Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.
Discover the newest research about AI innovations in ⌚ Wearables.

Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.

A new foundation model shows that overnight pulse oximetry data contains deep physiological signatures that can predict future hypertension and next-day blood sugar levels.

A quiet regulatory truce reveals exactly how far consumer wearables can push into clinical territory without triggering a federal crackdown.

A new AI system identifies a reversible “pre-disease” window for depression, proving that treatment timing matters more than the tool itself.

A new partnership between a smart ring maker and a pharmaceutical giant reveals how drugmakers are using consumer hardware to keep patients compliant.

Smartwatches and rings are marketed as lifesaving heart monitors, but new data shows their single-lead AI systems fail the very patients who need them most.

Putting medical-grade metabolic tracking directly into the hands of parents bypasses the clinic but shifts a heavy burden of clinical interpretation to the living room.

AI wearables for elderly care: 1.4 billion seniors by 2030. Privacy concerns demand robust governance frameworks. 📊🔒

Innovative PBGT hydrogels show >500% elasticity, rapid self-healing, and high sensitivity for wearable sensors. ⚡🧪

Revolutionary vibration sensors using MoS₂ achieve gauge factors of 5300, enhancing health monitoring and robotics. 🩺🤖